Endo maps out Men’s Health Month awareness, education drive

Endo is taking advantage of June’s status as Men’s Health Month to encourage men to prioritize their physical, mental and sexual health.

The Pennsylvania-based pharma on Monday laid out a list of activities it has planned for the coming weeks, all meant to raise awareness of and improve education around men’s health issues.

The campaign is targeting both patients and healthcare providers, with a specific focus on what Endo characterized as “commonly underdiagnosed and stigmatized conditions” affecting men, including Peyronie’s disease, erectile dysfunction and testosterone deficiency.

In addition to reaching men and their doctors digitally via social media, online ads and HCP-focused email campaigns, Endo will distribute educational materials in healthcare settings. 

The company also plans to share more stories and information about managing men’s health on its website; one newly published page includes data about the aforementioned trio of conditions and encourages readers to “speak up and take control” by talking to a doctor about any health concerns.

Elsewhere in the awareness month campaign, Endo said it will participate in “Wear Blue Day” on June 13, in which individuals and organizations are invited to dress in blue and host events to draw attention to men’s health issues.

“Men may not always be the strongest advocates for their own health, but with the right information and awareness, we can empower them to take a more active role in their well-being,” Justin Mattice, general manager of Endo’s branded specialty business, said in the announcement.

Endo’s product portfolio includes drugs to treat the aforementioned conditions and others that largely affect men: In addition to several testosterone drugs, it also sells erectile dysfunction injection Edex, as well as Xiaflex for both Peyronie’s and Dupuytren’s contracture, another condition more common in men than women.

The company has worked to raise awareness of and encourage more open discussions about both Peyronie’s and Dupuytren’s with recent direct-to-consumer campaigns. An unbranded TV commercial earlier this year encourages men to “get somebody” to whom they can talk about Peyronie’s, while another that debuted last summer pushed people with Dupuytren’s to find a hand specialist to learn more about all available treatment options.